EW - Edwards Lifesciences Corporation

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 535.21B
Enterprise Value 334.8B
Trailing P/E 50.68
Forward P/E 132.32
PEG Ratio (5 yr expected) 12.44
Price/Sales (ttm)9.69
Price/Book (mrq)10.48
Enterprise Value/Revenue 39.58
Enterprise Value/EBITDA 631.62

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Sep 30, 2018

Profitability

Profit Margin 19.61%
Operating Margin (ttm)28.12%

Management Effectiveness

Return on Assets (ttm)11.16%
Return on Equity (ttm)21.84%

Income Statement

Revenue (ttm)3.63B
Revenue Per Share (ttm)17.32
Quarterly Revenue Growth (yoy)10.40%
Gross Profit (ttm)2.56B
EBITDA 1.1B
Net Income Avi to Common (ttm)712.4M
Diluted EPS (ttm)3.32
Quarterly Earnings Growth (yoy)32.80%

Balance Sheet

Total Cash (mrq)1.6B
Total Cash Per Share (mrq)7.63
Total Debt (mrq)1.19B
Total Debt/Equity (mrq)35.51
Current Ratio (mrq)2.31
Book Value Per Share (mrq)16.08

Cash Flow Statement

Operating Cash Flow (ttm)997.7M
Levered Free Cash Flow (ttm)306.8M

Trading Information

Stock Price History

Beta (3Y Monthly) 0.82
52-Week Change 327.79%
S&P500 52-Week Change 3-6.95%
52 Week High 3175.00
52 Week Low 3121.40
50-Day Moving Average 3155.09
200-Day Moving Average 3149.86

Share Statistics

Avg Vol (3 month) 31.48M
Avg Vol (10 day) 31.81M
Shares Outstanding 5209.05M
Float 207.63M
% Held by Insiders 13.94%
% Held by Institutions 10.00%
Shares Short (Dec 31, 2018) 42.78M
Short Ratio (Dec 31, 2018) 42.1
Short % of Float (Dec 31, 2018) 41.48%
Short % of Shares Outstanding (Dec 31, 2018) 41.33%
Shares Short (prior month Nov 30, 2018) 42.69M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/2
Last Split Date 3Dec 14, 2015